drugset / Trial / NCT02479451

Helping Olfaction and Nutrition On Renal Replacement

NCT02479451

Phase 2 Completed 7 enrolled Massachusetts General Hospital
NaSingle-groupOpen-labelTreatment

Summary

This clinical trial examines whether nasal theophylline administration can improve olfaction and nutrition in hemodialysis patients.

Timeline

Start
2015-10
Primary completion
2022-07
Completion
2022-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Theophylline Small molecule 20 ug Intranasal